REKS koos Ravimitootjate Liiduga (RTL) korraldas virtuaalse ürituse “FMD ja Regulatoride Sümpoosion”, mis toimus 2. oktoober 2020 kell 10:00-14:00.

Üritus tõi kokku regulatiivküsimuste valdkonna spetsialistid Eestist, Lätist ja Leedust, aga ka sidusrühmi, proviisoreid, hulgimüüjaid ja logistikuid, et jagada parimaid võtmeteadmisi praegustel aktuaalsetel teemadel ning koos vaadata tulevikuväljavaateid.

ETTEKANDED

1. “Alert management in Finland and FiMVO’s experiences” – Maija Gohlke, General Manager of FiMVO PDF
2. “EMVO and the EMVS: Challenges and Future Opportunities” – Fanny Trenteseaux, Project & Partner Manager of European Medicines Verification Organisations (EMVO) PDF
3. “PIF and RA community, Nordic experiences sharing in artwork and package creation” – Anna Alonen, RA Manager, Medfiles Ltd, representing Pharma industry Finland (PIF)
4. “Risk Management Plans – ways of working” – Helen Shennan, RA Director, AstraZeneca Nordic Baltics MC, representing The Danish Association of the Pharmaceutical Industry (Lif)PDF
5. “Dear Doctor Letters and aRMM in RMP – expectations, practice and opportunities from regulator’s perspective” – Maia Uusküla, Head of Pharmacovigilance department of Estonian State Agency of Medicines PDF
6. “Multilingual Packaging” – Margit Plakso, Head of Marketing authorisations department of Estonian State Agency of Medicines PDF
7. “Industry recommendations to prevent medicines shortages” – Francois Lamérant, Senior Manager Economics & Social Affairs of EFPIA PDF
8. “Shortages and manufacturing resilience high on the EU pharma policy agenda” – Adrian van den Hoven, Director General of Medicines for Europe PDF